Topics
High-grade gliomas | Prognosis | Bevacizumab
Home > Publications > Topics > High-grade gliomas > Prognosis > Bevacizumab
Chaban A, Waschulzik B, Bernhardt
D, Delbridge C, Schmidt-Graf F, Wagner A, Wiestler B, Weber W,
Yakushev I.
Amino
acid PET vs. RANO MRI for prediction of overall survival in
patients with recurrent high grade glioma under bevacizumab
therapy.
Eur
J Nucl Med Mol Imaging.
2024 Jan 17. doi:
10.1007/s00259-024-06601-4. PMID:
38228970. Observational study. ˍ